Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.368
Sell
RSI(14)
21.959
Sell
STOCH(KDJ)(9,3,3)
4.834
Oversold
ATR(14)
0.807
High Vlolatility
CCI(14)
-98.717
Neutral
Williams %R
97.926
Oversold
TRIX(12,20)
-1.161
Sell
StochRSI(14)
0.000
Sell
TruBridge Inc
TBRG14.000USD
-0.850-5.72%
Close 03/30, 16:00（ET）Quotes delayed by 15 min
154.89MMarket Cap
62.18P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of TruBridge Inc
Currency: USD Updated: 2026-03-27Key Insights
TruBridge Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 51 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 22.60.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
TruBridge Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
TruBridge Inc Highlights
StrengthsRisks
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
Overvalued
The company’s latest PE is 62.49, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.40M shares, decreasing 18.42% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.18K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.29.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
22.600
Target Price
+52.19%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-27The current financial score of TruBridge Inc is 7.55, ranking 65 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 86.11M, representing a year-over-year increase of 2.72%, while its net profit experienced a year-over-year increase of 157.63%.
Score
Financials
6.16
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.05
Operational Efficiency
8.87
Growth Potential
6.49
Shareholder Returns
7.16
TruBridge Inc's Company Valuation
Currency: USD Updated: 2026-03-27The current valuation score of TruBridge Inc is 8.29, ranking 31 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 62.49, which is 67.66% below the recent high of 104.78 and 611.91% above the recent low of -319.92.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 51/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-27The current earnings forecast score of TruBridge Inc is 6.80, ranking 160 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 21.00, with a high of 26.00 and a low of 20.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
22.600
Target Price
+60.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
4
Median
7
Average
Company name
Ratings
Analysts
TruBridge Inc
TBRG
5
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-27The current price momentum score of TruBridge Inc is 6.61, ranking 98 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 17.90 and the support level at 12.14, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
14.478
Sell
MA10
14.930
Sell
MA20
16.603
Sell
MA50
18.648
Sell
MA100
20.146
Sell
MA200
20.565
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-27The current institutional shareholding score of TruBridge Inc is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 75.94%, representing a quarter-over-quarter increase of 10.06%. The largest institutional shareholder is The Vanguard, holding a total of 744.71K shares, representing 4.96% of shares outstanding, with 12.28% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Pinetree Capital Ltd.
Ocho Investments, L.L.C.
Rorema Beheer B.V.
Nellore Capital Management LLC
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
Martin & Company Investment Counsel
1
2
Risk Assessment
Currency: USD Updated: 2026-03-27The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of TruBridge Inc is 6.85, ranking 51 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.74. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. TruBridge Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.
Score
Beta vs S&P 500 index
0.74
VaR
+3.92%
240-Day Maximum Drawdown
+46.48%
240-Day Volatility
+46.73%
Return
Best Daily Return
60 days
+5.58%
120 days
+5.58%
5 years
+24.46%
Worst Daily Return
60 days
-10.46%
120 days
-10.46%
5 years
-19.66%
Sharpe Ratio
60 days
-3.85
120 days
-1.85
5 years
-0.23
Risk Assessment
Maximum Drawdown
240 days
+46.48%
3 years
+71.31%
5 years
+79.46%
Return-to-Drawdown Ratio
240 days
-0.91
3 years
-0.19
5 years
-0.15
Skewness
240 days
-0.82
3 years
+0.02
5 years
-0.40
Volatility
Realised Volatility
240 days
+46.73%
5 years
+45.53%
Standardised True Range
240 days
+5.86%
5 years
+5.75%
Downside Risk-Adjusted Return
120 days
-248.04%
240 days
-248.04%
Maximum Daily Upside Volatility
60 days
+38.32%
Maximum Daily Downside Volatility
60 days
+37.03%
Liquidity
Average Turnover Rate
60 days
+1.07%
120 days
+1.10%
5 years
--
Turnover Deviation
20 days
-28.62%
60 days
+3.09%
120 days
+5.69%
Peer Comparison
Healthcare Equipment & Supplies
TruBridge Inc
TBRG
7.20 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
